Cytek Biosciences 2024 J.P. Morgan Healthcare Conference

Cytek Biosciences presented its corporate strategy and financial outlook at the 2024 J.P. Morgan Healthcare Conference in January, highlighting flow cytometry and imaging capabilities following its acquisition of Luminex's cell analysis business. The company outlined its foundational four pillars: performance, regulatory intelligence, storage enabler, and ease of use, positioning itself as a leader in cell profiling and bioinformatics solutions.